Waddell & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,461
Closed -$152K 175
2023
Q3
$152K Sell
15,461
-386
-2% -$4.02K 0.02% 169
2023
Q2
$158K Buy
+15,847
New +$151K 0.02% 163
2022
Q4
Sell
-18,427
Closed -$157K 154
2022
Q3
$157K Sell
18,427
-673
-4% -$6.62K 0.03% 137
2022
Q2
$200K Buy
19,100
+3,199
+20% +$35.1K 0.04% 137
2022
Q1
$173K Buy
+15,901
New +$210K 0.03% 129
2021
Q4
Sell
-18,014
Closed -$244K 121
2021
Q3
$244K Buy
+18,014
New +$256K 0.04% 95

Other funds holding VTRS

Waddell & Associates's VTRS Position: Q4 2023 in Review

Waddell & Associates sold out of Viatris (VTRS) in Q4 2023, closing a stake of 15,461 shares — an estimated $152K sold.

Waddell & Associates first reported a position in VTRS in Q3 2021 and held it in 6 quarters. The position peaked at $244K in Q3 2021. 1,014 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Waddell & Associates reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Waddell & Associates sold 15,461 Viatris shares in Q4 2023, an estimated $152K.
  • Waddell & Associates first reported a position in Viatris in Q3 2021 and held it in 6 quarters.
  • Waddell & Associates's Viatris position peaked at $244K in Q3 2021.
  • 1,014 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Waddell & Associates's 13F filing for Q4 2023, filed 14 Feb 2024.